SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Ibotta, Inc. Investors

NEW YORK, 17 August 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Ibotta, Inc. (“Ibotta” or the “Company”) (NYSE: IBTA). Such investors are encouraged to contact Danielle Peyton at [email protected] or 646-581-9980, extension 7980.

The investigation concerns whether Ibotta and certain of its officers and/or directors engaged in securities transactions. Fraud or other unlawful business practices.

[Click here for information about joining the class action]

On or around 13 April 2024Ibotta conducted its initial public offering (“IPO”) with 6.6 million shares at a price of 88,00 € per share.

Then, on 13 August 2024Ibotta released a press release with financial results for the second quarter of 2024. Among other things, Ibotta reported a net loss of 34.0 million US dollarsburdened by operating costs that more than doubled year-on-year. The company also issued a revenue forecast for the third quarter in the range of 91 million US dollars To 96 million US dollarsbelow consensus estimates.

Following this news, Ibotta’s share price fell sharply in intraday trading. 14 August 2024.

Pomerantz LLP, with offices in new York, Chicago, Los Angeles, London, ParisAnd Tel-Avivis considered one of the leading law firms in the areas of corporate, securities and antitrust litigation. Founded by the late Abraham L. PomerantzKnown as the dean of class action lawyers, Pomerantz was a pioneer in the field of securities class action litigation. Today, more than 85 years later, Pomerantz continues the tradition he established and fights for the rights of securities litigation victims. FraudBreach of fiduciary duty and corporate misconduct. The firm has won billions of dollars in damages on behalf of class action plaintiffs. See www.pomlaw.com.

Attorney advertising. Past results do not guarantee similar results.

CONTACT:
Danielle Peyton
Pomerantz LLP
[email protected]
646-581-9980 extension 7980

Never miss a story from Pomerantz LLP again.